Abstract
Exposure assessment is an integral part of health risk characterization. Exposure assessments typically address three critical aspects of exposure: the number of people exposed to the environmental toxicant, at specific concentrations, for the time period of interest; the resulting dose; and the relative contribution of important sources and pathways to exposure/dose. Because historically both "point-of-contact" measurements and information about dose and related pharmacokinetic processes have been lacking, exposure assessments have had to rely on construction of "scenarios" to estimate exposure and dose. This could change, however, as advances in development of biologic markers of exposure and dose make it possible to measure and interpret toxicant concentrations in accessible human tissues. The increasing availability of "biomarkers," coupled with improvements in pharmacokinetic understanding, present opportunities to estimate ("reconstruct") exposure from measurements of dose and knowledge of intake and uptake parameters. Human tissue monitoring, however, is not a substitute for more traditional methods of measuring exposure, but rather a complementary approach. A combination of exposure measurements and dose measurements provides the most credible scientific basis for exposure assessment.
Full text
PDF
















Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burke T., Anderson H., Beach N., Colome S., Drew R. T., Firestone M., Hauchman F. S., Miller T. O., Wagener D. K., Zeise L. Role of exposure databases in risk management. Arch Environ Health. 1992 Nov-Dec;47(6):421–429. doi: 10.1080/00039896.1992.9938383. [DOI] [PubMed] [Google Scholar]
- Fowle J. R., 3rd, Sexton K. EPA priorities for biologic markers research in environmental health. Environ Health Perspect. 1992 Nov;98:235–241. doi: 10.1289/ehp.9298235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldman L. R., Gomez M., Greenfield S., Hall L., Hulka B. S., Kaye W. E., Lybarger J. A., McKenzie D. H., Murphy R. S., Wellington D. G. Use of exposure databases for status and trends analysis. Arch Environ Health. 1992 Nov-Dec;47(6):430–438. doi: 10.1080/00039896.1992.9938384. [DOI] [PubMed] [Google Scholar]
- Graham J., Walker K. D., Berry M., Bryan E. F., Callahan M. A., Fan A., Finley B., Lynch J., McKone T., Ozkaynak H. Role of exposure databases in risk assessment. Arch Environ Health. 1992 Nov-Dec;47(6):408–420. doi: 10.1080/00039896.1992.9938382. [DOI] [PubMed] [Google Scholar]
- Hattis D. B. The promise of molecular epidemiology for quantitative risk assessment. Risk Anal. 1986 Jun;6(2):181–193. doi: 10.1111/j.1539-6924.1986.tb00206.x. [DOI] [PubMed] [Google Scholar]
- Hawkins N. C. Conservatism in maximally exposed individual (MEI) predictive exposure assessments: a first-cut analysis. Regul Toxicol Pharmacol. 1991 Oct;14(2):107–117. doi: 10.1016/0273-2300(91)90001-c. [DOI] [PubMed] [Google Scholar]
- Hawkins N. C., Jayjock M. A., Lynch J. A rationale and framework for establishing the quality of human exposure assessments. Am Ind Hyg Assoc J. 1992 Jan;53(1):34–41. doi: 10.1080/15298669291359276. [DOI] [PubMed] [Google Scholar]
- Matanoski G., Selevan S. G., Akland G., Bornschein R. L., Dockery D., Edmonds L., Greife A., Mehlman M., Shaw G. M., Elliott E. Role of exposure databases in epidemiology. Arch Environ Health. 1992 Nov-Dec;47(6):439–446. doi: 10.1080/00039896.1992.9938385. [DOI] [PubMed] [Google Scholar]
- McKone T. E., Daniels J. I. Estimating human exposure through multiple pathways from air, water, and soil. Regul Toxicol Pharmacol. 1991 Feb;13(1):36–61. doi: 10.1016/0273-2300(91)90040-3. [DOI] [PubMed] [Google Scholar]
- McKone T. E. Human exposure to chemicals from multiple media and through multiple pathways: research overview and comments. Risk Anal. 1991 Mar;11(1):5–10. doi: 10.1111/j.1539-6924.1991.tb00556.x. [DOI] [PubMed] [Google Scholar]
- Schulte P. A. A conceptual framework for the validation and use of biologic markers. Environ Res. 1989 Apr;48(2):129–144. doi: 10.1016/s0013-9351(89)80029-5. [DOI] [PubMed] [Google Scholar]
- Sexton K., Olden K., Johnson B. L. "Environmental justice": the central role of research in establishing a credible scientific foundation for informed decision making. Toxicol Ind Health. 1993 Sep-Oct;9(5):685–727. doi: 10.1177/074823379300900504. [DOI] [PubMed] [Google Scholar]
- Sexton K., Selevan S. G., Wagener D. K., Lybarger J. A. Estimating human exposures to environmental pollutants: availability and utility of existing databases. Arch Environ Health. 1992 Nov-Dec;47(6):398–407. doi: 10.1080/00039896.1992.9938381. [DOI] [PubMed] [Google Scholar]
- Sexton K. The role of scientific research in risk assessment and risk management decisions. Otolaryngol Head Neck Surg. 1992 Jun;106(6):635–641. doi: 10.1177/019459989210600604. [DOI] [PubMed] [Google Scholar]
- Stevens D. K., Bull R. J., Nauman C. H., Blancato J. N. Decision model for biomarkers of exposure. Regul Toxicol Pharmacol. 1991 Dec;14(3):286–296. doi: 10.1016/0273-2300(91)90031-p. [DOI] [PubMed] [Google Scholar]
- Wallace L. A decade of studies of human exposure: what have we learned? Risk Anal. 1993 Apr;13(2):135–139. doi: 10.1111/j.1539-6924.1993.tb01059.x. [DOI] [PubMed] [Google Scholar]
- Wallace L., Nelson W., Ziegenfus R., Pellizzari E., Michael L., Whitmore R., Zelon H., Hartwell T., Perritt R., Westerdahl D. The Los Angeles TEAM Study: personal exposures, indoor-outdoor air concentrations, and breath concentrations of 25 volatile organic compounds. J Expo Anal Environ Epidemiol. 1991 Apr;1(2):157–192. [PubMed] [Google Scholar]
- Whitmyre G. K., Driver J. H., Ginevan M. E., Tardiff R. G., Baker S. R. Human exposure assessment. I: Understanding the uncertainties. Toxicol Ind Health. 1992 Sep-Oct;8(5):297–320. [PubMed] [Google Scholar]
- Whitmyre G. K., Driver J. H., Ginevan M. E., Tardiff R. G., Baker S. R. Human exposure assessment. II: Quantifying and reducing the uncertainties. Toxicol Ind Health. 1992 Sep-Oct;8(5):321–342. [PubMed] [Google Scholar]